The founder of BioVenture Publishing Inc. and BioVenture Consultants, Cynthia Robbins-Roth has been part of the biotechnology industry since 1981. A frequent speaker on issues and events affecting the industry, she combines a technical background with extensive experience in the business and finance issues that drive this growing sector. Dr. Robbins-Roth holds a Ph.D. in Biochemistry from the University of Texas Medical Branch, completed post-doctoral work in its Microbiology Department, and was a research scientist within the Immunology and Protein Biochemistry groups at Genentech, Inc. She then joined the Business Development group at California Biotechnology Inc. (Mountain View, California).

Dr. Robbins-Roth has been a consultant to the Bioscience Industry since 1986, providing technology assessment, competitor analysis, strategic planning, due diligence, market analysis and fund management consultation services. Her clients include major venture capital firms, established pharmaceutical companies, and early-stage biotechnology companies. Dr. Robbins-Roth is a member of the Board of Directors of Xavos Corp. and NewBiotics, early-stage biotechnology companies.

Dr. Robbins-Roth founded and continues as editor-in-chief of BioVenture Publishing, now a division of PJB Publications (which also publishes Scrip and Pharmaprojects). This firm produces BioVenture View, a monthly newsletter covering key business and product developments, financial transactions, and emerging technologies that will impact the industry and lead to the formation of new companies, and BIOPEOPLE Magazine. She was the founding Editor-in-Chief (1989 - 1991) of BioWorld Publications, a daily biotechnology news and information service. She is the editor and author of "Alternative Careers in Science: Leaving the Ivory Tower" (Academic Press) and writes a biotechnology column for Forbes Magazine.